Naomi Tsurikisawa Selected Research

Naomi Tsurikisawa Research Topics

Disease

32	Asthma (Bronchial Asthma) 02/2022 - 02/2006
9	Churg-Strauss Syndrome (Allergic Angiitis) 02/2022 - 01/2004
9	Inflammation (Inflammations) 10/2010 - 02/2007
6	Vasculitis (Vasculitides) 02/2022 - 01/2013
2	Heart Failure 02/2022 - 01/2014
2	Rhinitis 01/2022 - 08/2008
2	Eosinophilia 10/2018 - 03/2007
2	Cough 01/2015 - 12/2008
2	Mononeuropathies (Mononeuritis Multiplex) 01/2014 - 05/2012
2	Airway Obstruction (Choking) 03/2012 - 03/2007
2	Respiratory Hypersensitivity 03/2012 - 01/2011
2	Airway Remodeling 10/2010 - 09/2010
2	Hypersensitivity (Allergy) 12/2008 - 02/2006
1	Polyneuropathies (Polyneuropathy) 02/2022
1	Thrombosis (Thrombus) 02/2022
1	Pulmonary Embolism 02/2022
1	Allergic Rhinitis 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Occupational Asthma 11/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 08/2020
1	Carrington syndrome 10/2018
1	Rare Diseases (Rare Disease) 07/2013
1	Mesenteric Ischemia 01/2013
1	Hemorrhage 01/2013
1	Hypoxia (Hypoxemia) 05/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2011
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2011
1	Hypertrophy 10/2010
1	Hyperplasia 10/2010
1	Relapsing Polychondritis 03/2009
1	Disease Progression 08/2008
1	Chronic Cough 05/2008
1	Cardiomyopathies (Cardiomyopathy) 06/2007

Drug/Important Bio-Agent (IBA)

14	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 01/2004
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2011 - 02/2007
7	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2015 - 02/2006
5	Histamine (Histamine Dihydrochloride)FDA Link 01/2015 - 09/2010
5	SteroidsIBA 01/2013 - 03/2007
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2014 - 01/2004
4	CytokinesIBA 01/2013 - 09/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2022 - 01/2004
3	AllergensIBA 01/2022 - 11/2013
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 05/2012
3	Interleukin-10 (Interleukin 10)IBA 05/2018 - 09/2008
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2013 - 03/2011
3	Bronchodilator Agents (Bronchodilators)IBA 03/2012 - 03/2007
2	mepolizumabIBA 02/2022 - 01/2021
2	Immunoglobulin E (IgE)IBA 01/2021 - 02/2010
2	Interleukin-33IBA 10/2018 - 05/2018
2	cysteinyl-leukotrieneIBA 03/2011 - 02/2008
2	Interleukin-2 (IL2)IBA 01/2011 - 09/2008
2	AntigensIBA 02/2010 - 05/2007
2	Biomarkers (Surrogate Marker)IBA 02/2008 - 02/2007
1	Rituximab (Mabthera)FDA Link 02/2022
1	dupilumabIBA 02/2022
1	Oxygen (Dioxygen)IBA 02/2022
1	Furocoumarins (Furanocoumarins)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2021
1	LactoferrinIBA 11/2020
1	23-valent pneumococcal capsular polysaccharide vaccineIBA 08/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2015
1	ImmunosorbentsIBA 11/2013
1	Dermatophagoides pteronyssinus antigen p 1IBA 11/2013
1	EnzymesIBA 11/2013
1	Alprostadil (Muse)FDA LinkGeneric 01/2013
1	Prednisolone (Predate)FDA LinkGeneric 01/2013
1	LipopolysaccharidesIBA 01/2013
1	Interleukin-27 (Interleukin 27)IBA 01/2013
1	Interleukin-23 Subunit p19IBA 01/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2013
1	Interleukin-17 (Interleukin 17)IBA 01/2013
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2011
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2011
1	Celecoxib (Celebrex)FDA Link 05/2011
1	Leukotriene E4IBA 03/2011
1	Leukotriene B4IBA 03/2011
1	LeukotrienesIBA 03/2011
1	Leukotriene C4IBA 03/2011
1	Leukotriene D4IBA 03/2011
1	3-Iodobenzylguanidine (Iobenguane)IBA 02/2011
1	InterleukinsIBA 01/2011
1	TenascinIBA 10/2010
1	Interleukin-3 (Interleukin 3)IBA 02/2010
1	anti-IgE antibodiesIBA 02/2010
1	Fluticasone (Cutivate)FDA LinkGeneric 03/2009
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 12/2008
1	Interleukin-5 (Interleukin 5)IBA 09/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2008
1	Anti-Allergic Agents (Antiallergic Agents)IBA 08/2008
1	Dust (House Dust)FDA Link 05/2007
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2007

Therapy/Procedure

8	Therapeutics 02/2022 - 06/2007
2	Drug Tapering 05/2018 - 09/2012
2	Aftercare (After-Treatment) 01/2013 - 03/2007
1	Catheters 01/2013
1	Remission Induction 06/2007